Business
Gencor Announces NYSE American Acceptance of Compliance Plan
ORLANDO, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today that NYSE American LLC (“NYSE American”) notified the Company that NYSE Regulation (“NYSE”) accepted the Company’s request for an extension to regain compliance with Sections 134 and 1101 of the NYSE American’s continued listing standards, granting the Company a plan period through August 19, 2025 (the “New Cure Deadline”) to submit its delinquent reports. Th
About this update from Gencor Industries, Inc.
[{"type":"text","content":"ORLANDO, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) announced today that NYSE American LLC (“NYSE American”) notified the Company that NYSE Regulation (“NYSE”) accepted the Company’s request for an extension to regain compliance with Sections 134 and 1101 of the NYSE American’s continued listing standards, granting the Company a plan period through August 19, 2025 (the “New Cure Deadline”) to submit its delinquent reports.","length":497,"tagName":"p"},{"type":"text","content":"The Company requested the extension to allow it additional time to coordinate the completion of its Quarterly Reports on Form 10-Q for the quarterly periods ended December 31, 2024 and March 31, 2025. While the Company is currently not in compliance with the NYSE American continued listing standards as a result of its failure to timely file with the Securities and Exchange Commission its Annual Report on Form 10-K for the year ended September 30, 2024 as well as its Quarterly Reports on Form 10-Q for the quarterly periods ended December 31, 2024 and March 31, 2025, its listing is being continued pursuant to the extension. The Company will be subject to periodic review by NYSE during the extension period. Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the extension period could result in the Company being delisted from the NYSE American.","length":926,"tagName":"p"},{"type":"text","content":"The Company currently expects to file its Annual Report on Form 10-K for the year ended September 30, 2024 within the initial six-month period and its Quarterly Reports on Form 10-Q for the quarterly periods ended December 31, 2024 and March 31, 2025 by the New Cure Deadline; however, there can be no assurance that the delinquent reports will be filed within such periods.","length":374,"tagName":"p"},{"type":"text","content":"Gencor Industries, Inc. is a diversified heavy machinery manufacturer for the production of highway construction materials and equipment and environmental control machinery and equipment used in a variety of applications.","length":221,"tagName":"p"},{"type":"text","content":"Caution Concerning Forward Looking Statements - This press release and our other communications and statements may contain certa...